List of insiders holdings for Calithera Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Delphi Management Partners VIII L.L.C. DELPHI VENTURES VIII LP Delphi BioInvestments VIII LP ROEDER DOUGLAS A DOUGLASS DAVID L BOCHNOWSKI JAMES J PAKIANATHAN DEEPIKA 10% Owner | 2020-02-07 06:12:41 | 2,475,285 0 | 2,475,285 | Form 13D |
| Christoffersen Ralph E Director 10% Owner | 2014-10-09 16:41:33 | 0 2,161,915 | 2,161,915 | Form 4 |
| Advanced Technology Ventures VIII LP ATV Associates VIII L.L.C. 10% Owner | 2014-10-17 16:06:27 | 2,110,082 0 | 2,110,082 | Form 13D |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner | 2023-02-14 11:48:11 | 488,367 0 | 488,367 | Form 13G |
| Hecht Curtis CHIEF BUSINESS OFFICER | 2021-01-22 20:45:59 | 242,321 0 | 242,321 | Form 4 |
| DRACHMAN JONATHAN G Director | 2021-11-10 19:31:30 | 200,000 0 | 200,000 | Form 4 |
| Ray Sumita See Remarks | 2022-01-27 16:17:03 | 165,000 0 | 165,000 | Form 4 |
| Parlati Francesco SR. VP, RESEARCH | 2022-01-27 16:15:00 | 165,000 0 | 165,000 | Form 4 |
| Waddill William D. SR. VP & CFO | 2016-12-01 16:05:42 | 75,000 0 | 75,000 | Form 4 |
| Bennett Mark K SR. VP, RESEARCH | 2016-12-01 16:06:38 | 56,250 0 | 56,250 | Form 4 |
| Molineaux Christopher SR. VP, DEVELOPMENT | 2023-01-25 16:00:12 | 5283 32,583 | 37,866 | Form 4 |
| Molineaux Susan PRESIDENT & CEO | 2023-01-25 16:00:17 | 4724 33,142 | 37,866 | Form 4 |
| George Jean Director | 2021-06-14 16:05:23 | 20,000 0 | 20,000 | Form 4 |
| Wise Blake Director | 2022-06-03 16:05:26 | 20,000 0 | 20,000 | Form 4 |
| Wolff Henry Ward Director | 2022-06-03 16:05:18 | 20,000 0 | 20,000 | Form 4 |
| Orford Keith Director | 2022-06-03 16:05:20 | 20,000 0 | 20,000 | Form 4 |
| Garland J. Scott Director | 2022-06-03 16:05:34 | 20,000 0 | 20,000 | Form 4 |
| AGARWAL SUNIL Director | 2022-06-03 16:05:34 | 20,000 0 | 20,000 | Form 4 |
| JONES SUZY Director | 2022-06-03 16:05:47 | 20,000 0 | 20,000 | Form 4 |
| Sjogren Eric SR. VP, DRUG DISCOVERY | 2023-01-25 16:00:25 | 8467 0 | 8467 | Form 4 |
| Wong Stephanie See Remarks | 2023-01-25 16:00:16 | 6287 360 | 6647 | Form 4 |
| Kuriakose Emil CHIEF MEDICAL OFFICER | 2023-01-25 16:00:21 | 3539 0 | 3539 | Form 4 |
| PAKIANATHAN DEEPIKA Director | 2023-01-31 19:04:07 | 0 0 | 0 | Form 4 |
| TAKEDA PHARMACEUTICAL CO LTD Takeda Ventures Inc. Former 10% Owner | 2023-05-26 07:08:52 | 0 0 | 0 | Form 13D |
| TAKEDA PHARMACEUTICAL CO LTD MILLENNIUM PHARMACEUTICALS INC 10% Owner | 2023-05-26 07:08:52 | 0 0 | 0 | Form 13D |
| ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 2022-02-10 09:12:30 | 0 0 | 0 | Form 13G |
| MORGENTHALER VENTURE PARTNERS IX LP 10% Owner | 2018-02-14 14:00:27 | 0 0 | 0 | Form 13G |